Cardax Company Top Insiders
| CDXI Stock | USD 0.0001 0.00 0.00% |
Cardax employs about 10 people. The company is managed by 3 executives with a total tenure of roughly 16 years, averaging almost 5.0 years of service per executive, having 3.33 employees per reported executive. Assessment of Cardax's management performance can provide insight into the firm performance.
| Gilbert Shin President Vice President - Retail Sales and Marketing |
Cardax |
Cardax Management Team Effectiveness
The company has return on total asset (ROA) of (1.1256) % which means that it has lost $1.1256 on every $100 spent on assets. This is way below average. Cardax's management efficiency ratios could be used to measure how well Cardax manages its routine affairs as well as how well it operates its assets and liabilities.Cardax Workforce Comparison
Cardax Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,962. Cardax adds roughly 10.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Cardax Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cardax Inc Price Series Summation is a cross summation of Cardax price series and its benchmark/peer.
Cardax Notable Stakeholders
A Cardax stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cardax often face trade-offs trying to please all of them. Cardax's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cardax's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gilbert Shin | Vice President - Retail Sales and Marketing | Profile | |
| David Watumull | VP of Operations, Assistant Treasurer and Assistant Secretary | Profile | |
| Jon MD | Chief Officer | Profile |
About Cardax Management Performance
The success or failure of an entity such as Cardax Inc often depends on how effective the management is. Cardax management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cardax management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cardax management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Cardax Workforce Analysis
Traditionally, organizations such as Cardax use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cardax within its industry.Cardax Manpower Efficiency
Return on Cardax Manpower
| Revenue Per Employee | 53.9K | |
| Revenue Per Executive | 179.6K | |
| Net Loss Per Employee | 505.6K | |
| Net Loss Per Executive | 1.7M |
Complementary Tools for Cardax Pink Sheet analysis
When running Cardax's price analysis, check to measure Cardax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardax is operating at the current time. Most of Cardax's value examination focuses on studying past and present price action to predict the probability of Cardax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardax's price. Additionally, you may evaluate how the addition of Cardax to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |